4,5-diphenylthiophene-2-carboxylic acid | 40133-11-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: 4,5-diphenylthiophene-2-carboxylic acid
• CAS: 40133-11-7
• 化学式: C₁₇H₁₂O₂S
• 分子量: 280.347
• InChiKey: PIZARWKKSUCXLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  65.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4,5-diphenylthiophene-2-carboxylic acid 在 水 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 、 lithium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 17.0h， 生成 2-[Cyclopentyl-(4,5-diphenylthiophene-2-carbonyl)amino]acetic acid
  参考文献：
  名称：

  WO2024009283A1

  摘要：

  公开号：
• 作为产物：
  描述：

  ethyl 4,5-diphenylthiophene-2-carboxylate 在 水 、 lithium hydroxide 作用下， 以 四氢呋喃 为溶剂， 以91 %的产率得到4,5-diphenylthiophene-2-carboxylic acid
  参考文献：
  名称：

  WO2024009283A1

  摘要：

  公开号：

文献信息

• THIOPHENE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
  申请人：Barth Francis

  公开号：US20110183960A1

  公开（公告）日：2011-07-28

  The subject matter of the invention is compounds corresponding to formula (I), in which: R 1 and R 2 , together with the nitrogen atom to which they are attached, constitute a saturated heterocyclic radical containing from 4 to 7 atoms, which is preferably substituted; one of the two substituents R 3 and R 6 is a group Y-A-R 9 ; Y is an oxygen atom or an —S(O) n′ —, or —OSO 2 group; A is an unsubstituted (C 1 -C 4 ) alkylene group; R 9 is an —OR 19 , —CH 3 , —NR 19 R 20 , —CONR 19 R 20 , —NR 15 COR 19 , —S(O) n R 21 , or —NR 13 SO 2 R 21 group; —R 10 is a hydrogen atom or a (C 1 -C 4 ) alkyl group. The present invention also relates to the methods of preparation and the therapeutic uses of the compounds of formula (I).

  本发明涉及与式（I）相对应的化合物，其中：R1和R2与它们连接的氮原子一起构成一个饱和的杂环基团，含有4到7个原子，最好是取代的；两个取代基R3和R6中的一个是一个Y-A-R9基团；Y是氧原子或-S(O)n′-或-OSO2基团；A是未取代的（C1-C4）烷基基团；R9是-OR19，-CH3，-NR19R20，-CONR19R20，-NR15COR19，-S(O)nR21或-NR13SO2R21基团；-R10是氢原子或（C1-C4）烷基基团。本发明还涉及制备方法和化合物（I）的治疗用途。
• [EN] CYSTEINE PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE LA CYSTEINE PROTEASE
  申请人：AXYS PHARM INC

  公开号：WO2003097617A1

  公开（公告）日：2003-11-27

  The present invention is directed to compounds that are inhibitors of cysteine protease, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是包括B、K、L、F和S型半胱氨酸蛋白酶，在治疗由这些蛋白酶介导的疾病中具有用途。本发明涉及包括这些化合物的药物组合物和其制备方法。
• [EN] MODULATORS OF C3A RECEPTORS<br/>[FR] MODULATEURS DES RÉCEPTEURS C3A
  申请人：UNIV QUEENSLAND

  公开号：WO2013067578A1

  公开（公告）日：2013-05-16

  Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated cardiovascular diseases are described. The use of the compounds in stimulating or suppressing an immune response is also described together with pharmaceutical compositions comprising the compounds or their pharmaceutically acceptable salts.

  描述了调节C3a受体的杂环化合物及其在治疗或预防炎症性疾病、传染病、癌症、代谢紊乱、肥胖、2型糖尿病、代谢综合征以及相关心血管疾病中的用途。还描述了这些化合物在刺激或抑制免疫反应中的用途，以及包含这些化合物或其药用可接受盐的制药组合物。
• Cyanomethyl derivatives as cysteine protease inhibitors
  申请人：Graupe Michael

  公开号：US20060122184A1

  公开（公告）日：2006-06-08

  The present invention is directed to cyanomethyl derivatives that are inhibitors of cysteine protease, in particular, cathepsin B, K, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及氰甲基衍生物，其是半胱氨酸蛋白酶的抑制剂，特别是对于B、K、F和S型的卡特普辛，因此可用于治疗由这些蛋白酶介导的疾病。本发明还涉及包含这些化合物的制药组合物和其制备过程。
• Hetero cyclic metallocene compounds and use thereof in catalyst system for producing olefin polymers
  申请人：——

  公开号：US20030036612A1

  公开（公告）日：2003-02-20

  1 A metallocene compound of general formula (I): LGZMXp, wherein L is a divalent group, Z is a moiety of formula (II), wherein R 3 and R 4 are selected from hydrogen and hydrocarbon groups; A and B are selected from S, O or CR 5 , wherein R 5 is selected from hydrogen and hydrocarbon groups, either A or B being different from CR 5 ; G is a moiety of formula (III), wherein R 6 , R 7 , R 8 and R 9 are selected from hydrogen and hydrocarbon groups, M is an atom of a transition metal, X is selected from a halogen atom, a R 10 , OR 10 , OSO 2 CF 3 , OCOR 10 , SR 10 , NR 10 2 or PR 10 2 group, wherein the substituents R 10 is hydrogen and a hydrocarbon group; p is an integer from 0 to 3.

  一种通式为(I)的1A金属茂化合物：LGZMXp，其中L是二价基团，Z是通式(II)的一部分，其中R3和R4选择自氢和烃基团；A和B选择自S、O或CR5，其中R5选择自氢和烃基团，A或B至少有一个不同于CR5；G是通式(III)的一部分，其中R6、R7、R8和R9选择自氢和烃基团，M是一个过渡金属原子，X选择自卤素原子、R10、OR10、OSO2CF3、OCOR10、SR10、NR102或PR102基团，其中取代基R10是氢和烃基团；p是从0到3的整数。